SLC7A11 and breast carcinoma: Breast cancer clinical data also showed that higher SLC7A11 expression was correlated with worse survival outcomes in lymph node-positive/metastatic patients but not in the lymph node-negative or overall patient population (Supplementary Fig. 7e).